Sonoma Pharmaceuticals (SNOA) Institutional Ownership $2.79 +0.11 (+4.10%) (As of 11/1/2024 ET) Add Compare Share Share Ownership Stock AnalysisChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsShort InterestTrends Institutional Ownership Changes (13F Filings) for Sonoma Pharmaceuticals (NASDAQ:SNOA)CurrentInstitutional OwnershipPercentage1.95%Number ofInstitutional Buyers(last 12 months)1TotalInstitutional Inflows(last 12 months)$31.93KNumber ofInstitutional Sellers(last 12 months)0 Get SNOA Insider Trade Alerts Want to know when executives and insiders are buying or selling Sonoma Pharmaceuticals stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data SNOA Institutional Buying and Selling by Quarter Ad InvestorPlaceWhy Buffett, Bezos, & Congress Are Piling Into This One SectorWhy are Warren Buffett, Jeff Bezos, Michael Bloomberg, “The Walmart Family”, Bill Gates, and 48 members of Congress shifting their stocks in a frenzy? And why are they all piling into ONE unique corner of the market…Click here for the details Sonoma Pharmaceuticals Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails10/29/2024 Ground Swell Capital LLC10,400$32K0.0%N/A1.083% 11/16/2021Squarepoint Ops LLC15,712$88K0.0%N/A0.751% 8/13/2021Renaissance Technologies LLC92,167$677K0.0%-6.7%4.406% 8/13/2021Geode Capital Management LLC30,181$221K0.0%N/A1.443% 8/13/2021Vanguard Group Inc.27,975$205K0.0%+44.9%1.337% 5/13/2021Renaissance Technologies LLC98,826$734K0.0%+7.7%4.758% 5/11/2021Acadian Asset Management LLC6,026$45K0.0%-29.5%0.290% 2/10/2021Renaissance Technologies LLC91,734$666K0.0%-3.2%4.421% (Data available from 1/1/2016 forward) SNOA Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of SNOA shares? During the previous two years, the following institutional investors and hedge funds held shares of Sonoma Pharmaceuticals shares: Ground Swell Capital LLC ($32K).Learn more on SNOA's institutional investors. What percentage of Sonoma Pharmaceuticals stock is owned by institutional investors? 1.95% of Sonoma Pharmaceuticals stock is owned by institutional investors. Learn more on SNOA's institutional investor holdings. Which institutional investors have been buying Sonoma Pharmaceuticals stock? The following institutional investors have purchased Sonoma Pharmaceuticals stock in the last 24 months: Ground Swell Capital LLC ($10.40K). How much institutional buying is happening at Sonoma Pharmaceuticals? Institutional investors have bought a total of 10,400 shares in the last 24 months. This purchase volume represents approximately $31.93K in transactions. Related Companies Vincerx Pharma Institutional Ownership Addex Therapeutics Institutional Ownership Edesa Biotech Institutional Ownership Indaptus Therapeutics Institutional Ownership RedHill Biopharma Institutional Ownership TransCode Therapeutics Institutional Ownership ABVC BioPharma Institutional Ownership Viracta Therapeutics Institutional Ownership Can-Fite BioPharma Institutional Ownership Cyclerion Therapeutics Institutional Ownership This page (NASDAQ:SNOA) was last updated on 11/2/2024 by MarketBeat.com Staff From Our PartnersEx WH Advisor Who Predicted Biden Leaving Race Makes Startling New PredictionFormer advisor to the CIA, the Pentagon and the White House Jim Rickards went on multiple TV news programs… ...Paradigm Press | Sponsored625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetche...Crypto Swap Profits | SponsoredSell NVDA Now?Guess who's selling NVDA next The most successful hedge fund in history quietly sold 500,000 shares. Here's...Chaikin Analytics | SponsoredMarket "Famine" ComingMarket Wizard Larry Benedict accurately predicted that all indexes would be negative in 2022... He predicte...Opportunistic Trader | SponsoredThe centerpiece of Trump’s crypto’s masterplan …Donald Trump wants to be America’s first crypto president. He was the keynote speaker at the recent Bitcoin...Weiss Ratings | SponsoredHow Will You Survive A Post Election Retirement Heist?The clock is ticking, and your life savings are in an extremely vulnerable position. We are a few days away...American Hartford Gold Group | SponsoredBlackrock’s Sending THIS Crypto Higher on PurposeIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | SponsoredI was wrong. Dead wrong. I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Sonoma Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Sonoma Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
